Claims
- 1. A transgenic plant comprising a recombinant polynucleotide having a polynucleotide sequence, or a complementary polynucleotide sequence thereof, selected from the group consisting of:
(a) a polynucleotide sequence encoding a polypeptide, wherein said polypeptide is selected from the group consisting of SEQ ID NO: 2N, wherein N=1-229, SEQ ID NO: 467; 488-490; 501-503; 505; 512-515; 521-522; 525-526; 528; 530; 534-537; 540; 558-559; 569; 587-594; 597; 607-609; 621-626; 635-639; 665-669; 708-713; 720-721; 736-739; 742; 780-807; 824; 835-837; 851-854; 865-867; 890-891; 903-907; 910-913; 922-923; 926; 933-934; 943; 953-960; 966-967; 987-988;994; 1011; 1035-1042; 1064-1073; 1081-1090; 1105-1110; 1122; 1129-1133; 1139-1141; 1157-1158; 1176-1186; 1191; 1200-1201; 1221-1248; 1254-1257; 1263; 1270; 1288-1291; 1302; 1310-1314; 1324-1327; 1338-1339; 1342-1343; 1362-1364; 1378; 1391-1392; 1395; 1399-1418; 1433; 1453-1454; 1457-1459; 1466-1467; 1492-1498; 1500-1501; 1503-1504; 1522; 1528; 1533-1535; 1540-1541; 1563-1566; 1572; 1583-1586; 1593-1594; 1621-1624; 1645-1646; 1655-1658; 1670; 1674; 1681; 1687; 1701-1705; 1710-1713; 1727; 1735-1737; 1743; 1754-1756; 1761-1762; 1765; 1769; 1781; 1785; 1790; 1805; 1813; 1838-1846; 1857; 1863; 1874-1875; 1883-1884; 1897-1901; 1911-1912; 1917-1920; 1929-1930; 1937-1939; 1942-1943; and SEQ ID NO: 2N, wherein N=974-1101; (b) a polynucleotide sequence encoding a polypeptide, wherein said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 2N-1, wherein N=1-229, SEQ ID NO: 459-466;468-487; 491-500; 504; 506-511; 516-520; 523-524; 527; 529; 531-533; 538-539; 541-557; 560-568; 570-586; 595-596; 598-606; 610-620; 627-634; 640-664; 670-707; 714-719; 722-735; 740-741; 743-779; 808-823; 825-834; 838-850; 855-864; 868-889; 892-902; 908-909; 914-921; 924-925; 927-932; 935-942; 944-952; 961-965; 968-986; 989-993; 995-1010; 1012-1034; 1043-1063; 1074-1080; 1091-1104; 1111-1121; 1123-1128; 1134-1138; 1142-1156; 1159-1175; 1187-1190; 1192-1199; 1202-1220; 1249-1253; 1258-1262; 1264-1269; 1271-1287; 1292-1301; 1303-1309; 1315-1323; 1328-1337; 1340-1341; 1344-1361; 1365-1377; 1379-1390; 1393-1394; 1396-1398; 1419-1432; 1434-1452; 1455-1456; 1460-1465; 1468-1491; 1499; 1502; 1505-1521; 1523-1527; 1529-1532; 1536-1539; 1542-1562; 1567-1571; 1573-1582; 1587-1592; 1595-1620; 1625-1644; 1647-1654; 1659-1669; 1671-1673; 1675-1680; 1682-1686; 1688-1700; 1706-1709; 1714-1726; 1728-1734; 1738-1742; 1744-1753; 1757-1760; 1763-1764; 1766-1768; 1770-1780; 1782-1784; 1786-1789; 1791-1804; 1806-1812; 1814-1837; 1847-1856; 1858-1862; 1864-1873; 1876-1882; 1885-1896; 1902-1910; 1913-1916; 1921-1928; 1931-1936; 1940-1941; 1944-1946, and SEQ ID NO: 2N-1, wherein N=974-1101; (c) a polynucleotide sequence encoding the polypeptide sequence of (a) with conservative substitutions as defined in Table 2, wherein said polypeptide sequence of (a) with conservative substitutions is a transcription factor; (d) a variant of the polynucleotide sequences of (a) or (b), which is at least 80% identical to a sequence of (a) or (b), and wherein said sequence variant encodes a polypeptide that is a transcription factor; (e) an orthologous sequence of the polynucleotide sequences of (a) or (b), which is at least 80% identical to a sequence of (a) or (b), and wherein said orthologous sequence encodes a polypeptide; (f) a paralogous sequence of the polynucleotide sequences of (a) or (b), which is at least 80% identical to a sequence of (a) or (b), and wherein said paralogous sequence encodes a polypeptide; (g) a polynucleotide sequence encoding a polypeptide comprising a conserved domain that exhibits at least 80% sequence homology with the conserved domain of the polypeptide of (a), wherein said polypeptide comprising a conserved domain of a transcription factor; and wherein said conserved domain of (a) is bounded by amino acid residue coordinates according to Table 5; and (h) a polynucleotide that hybridizes to the polynucleotide of (a) or (b) under stringent conditions.
- 2. The transgenic plant according to claim 1, wherein:
the transgenic plant possesses an altered trait as compared to a non-transformed plant; or the transgenic plant exhibits an altered phenotype as compared to said non-transformed plant; or the transgenic plant expresses an altered level of one or more genes associated with a plant trait as compared to said non-transformed plant; wherein said non-transformed plant does not overexpress the recombinant polynucleotide.
- 3. The transgenic plant according to claim 2, wherein said polynucleotide sequence is derived from a monocotyledonous plant.
- 4. The transgenic plant according to claim 3, wherein said transgenic plant is dicotyledenous.
- 5. The transgenic plant according to claim 2, wherein said polynucleotide sequence is derived from a dicotyledonous plant.
- 6. The transgenic plant according to claim 5, wherein said transgenic plant is monocotyledonous.
- 7. The transgenic plant according to claim 2, wherein the plant is selected from the group consisting of: soybean, wheat, corn, potato, cotton, rice, oilseed rape, sunflower, alfalfa, clover, sugarcane, turf, banana, blackberry, blueberry, strawberry, raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, mint and other labiates, rosaceous fruits, and vegetable brassicas.
- 8. The transgenic plant according to claim 2, wherein the encoded polypeptide of (a)-(h) is expressed and regulates transcription of a gene.
- 9. The transgenic plant according to claim 2, further comprising a constitutive, inducible, or tissue-specific promoter operably linked to said polynucleotide sequence or said complementary polynucleotide sequence.
- 10. The transgenic plant according to claim 2, wherein the encoded polypeptide of (a)-(h) is a sequence selected from the group consisting of SEQ ID NO: 2N, wherein N=1-229, and polynucleotide variants thereof.
- 11. The transgenic plant according to claim 10, wherein said altered trait is an enhanced tolerance to abiotic stress.
- 12. The transgenic plant according to claim 11, wherein said abiotic stress is increased tolerance to chilling and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 45, 139, 257, and polynucleotide variants thereof.
- 13. The transgenic plant according to claim 11, wherein said abiotic stress is increased germination in cold conditions and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 45, 139, and polynucleotide variants thereof.
- 14. The transgenic plant according to claim 11, wherein said abiotic stress is increased freezing tolerance and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 151, 185, 187, and polynucleotide variants thereof.
- 15. The transgenic plant according to claim 11, wherein said abiotic stress is increased tolerance to heat and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 81, 147, 167, 255, 347, 405, 435, and polynucleotide variants thereof.
- 16. The transgenic plant according to claim 11, wherein said abiotic stress is increased tolerance to drought and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 87, 185, 341, 437,, and polynucleotide variants thereof.
- 17. The transgenic plant according to claim 11, wherein said abiotic stress is increased tolerance to osmotic stress and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 11, 19, 25, 51, 55, 59, 93, 189, 191, 221, 229, 279, 335, 341, 353, 369, 417, 411, 417, 433, 451, 453, 455, 2141, and polynucleotide variants thereof.
- 18. The transgenic plant according to claim 11, wherein said abiotic stress is increased tolerance to salt and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 5, 31, 37, 53, 89, 103, 161, 169, 189, 343, 397, and polynucleotide variants thereof.
- 19. The transgenic plant according to claim 18, wherein said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 169 and polynucleotide variants thereof, and said transgenic plant has increased root growth or increased root hairs relative to non-transformed plant; wherein said non-transformed plant does not overexpress the recombinant polynucleotide.
- 20. The transgenic plant according to claim 19, wherein said enhanced tolerance to abiotic stress confers improved seed germination.
- 21. The transgenic plant according to claim 19, wherein said enhanced tolerance to abiotic stress confers improved seedling vigor.
- 22. The transgenic plant according to claim 11, wherein said abiotic stress is increased tolerance to nitrogen limitation and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 37, 331, 335, 2061, 2141, and polynucleotide variants thereof.
- 23. The transgenic plant according to claim 11, wherein said abiotic stress is increased tolerance to phosphate limitation and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 103, 107, 183, 375, and polynucleotide variants thereof.
- 24. The transgenic plant according to claim 11, wherein said abiotic stress is increased tolerance to oxidative stress and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 85 and polynucleotide variants thereof.
- 25. The transgenic plant according to claim 10, wherein said altered trait is glyphosate tolerance and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 57, 407, 441, and polynucleotide variants thereof.
- 26. The transgenic plant according to claim 10, wherein said altered trait is altered hormone sensitivity.
- 27. The transgenic plant according to claim 26, wherein said altered hormone sensitivity is reduced sensitivity to abscisic acid and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 105, 191, 221, 279, 341, 411, 455, and polynucleotide variants thereof.
- 28. The transgenic plant according to claim 26, wherein said altered hormone sensitivity is an altered response to ethylene and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 231, SEQ ID NO: 261, and polynucleotide variants thereof.
- 29. The transgenic plant according to claim 10, wherein said altered trait is disease resistance.
- 30. The transgenic plant according to claim 29, wherein said altered trait is altered susceptibility to Botrytis and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 9, 41, 67, 219, 227, 239, 249, 325, 331, 357, 365, 371, 381, 445, and polynucleotide variants thereof.
- 31. The transgenic plant according to claim 29, wherein said altered trait is altered susceptibility to Fusarium and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 25, 103, 179, 209, 331, and polynucleotide variants thereof.
- 32. The transgenic plant according to claim 29, wherein said altered trait is altered susceptibility to Erysiphe and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 3, 9, 73, 103, 175, 251, 267, 331, and polynucleotide variants thereof.
- 33. The transgenic plant according to claim 29, wherein said altered trait is altered susceptibility to Pseudomonas syringae and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 103 and polynucleotide variants thereof.
- 34. The transgenic plant according to claim 29, wherein said altered trait is altered susceptibility to Sclerotinia and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 9, 47, 85, 121, 367, 371, and polynucleotide variants thereof.
- 35. The transgenic plant according to claim 10, wherein said altered trait is altered sugar sensing and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 39, 43, 87, 111, 145, 169, 185, 243, 337, 2141, and polynucleotide variants thereof.
- 36. The transgenic plant according to claim 35, wherein said altered sugar sensing is increased tolerance to sugars and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 87 and polynucleotide variants thereof.
- 37. The transgenic plant according to claim 35, wherein said altered sugar sensing confers improved seed germination.
- 38. The transgenic plant according to claim 35, wherein said altered sugar sensing confers improved seedling vigor.
- 39. The transgenic plant according to claim 10, wherein said altered trait is early flowering and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 15, 21, 23, 95, 119, 159, 243, 291, 341, 347, 349, 351, 375, 387, 415, 423, 431, 439, 2009, and polynucleotide variants thereof.
- 40. The transgenic plant according to claim 10, wherein said altered trait is late flowering and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 1, 11, 15, 29, 35, 63, 65, 109, 153, 155,165, 181, 187, 195, 211, 213, 285, 337, 359, 385, 407, 419, and polynucleotide variants thereof.
- 41. The transgenic plant according to claim 10, wherein said altered trait is altered flower structure and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 59, 61, 83, 157, 133, 205, 217, 225, 233, 275, 295, 377, 413, 447 and polynucleotide variants thereof.
- 42. The transgenic plant according to claim 10, wherein said altered trait is an inflorescence architectural change and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 11, 217, 295, 311, 413, and polynucleotide variants thereof.
- 43. The transgenic plant according to claim 10, wherein said altered trait is a change in stem bifurcations and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 69, SEQ ID NO: 71, and polynucleotide variants thereof.
- 44. The transgenic plant according to claim 10, wherein said altered trait is an altered branching pattern and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 75, 113, 205, 303, 335, and polynucleotide variants thereof.
- 45. The transgenic plant according to claim 10, wherein said altered trait is reduced apical dominance and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 11, 33, 249, 253, 269, 289, 335, 439, and polynucleotide variants thereof.
- 46. The transgenic plant according to claim 10, wherein said altered trait is reduced trichome density or lack of trichomes and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 37, 117, 143, 147, 265, 279, 1979, 2141, and polynucleotide variants thereof.
- 47. The transgenic plant according to claim 10, wherein said altered trait is reduced ectopic trichome development or altered trichome development and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 65, 143, 1991, and polynucleotide variants thereof.
- 48. The transgenic plant according to claim 10, wherein said altered trait is an increase in trichome number and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 65, 127, 2197, and polynucleotide variants thereof.
- 49. The transgenic plant according to claim 10, wherein said altered trait is altered stem morphology and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 11, 77, 155, 205, 289, and polynucleotide variants thereof.
- 50. The transgenic plant according to claim 10, wherein said altered trait is increased root growth and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 287 and polynucleotide variants thereof.
- 51. The transgenic plant according to claim 10, wherein said altered trait is increased root hairs and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 37, SEQ ID NO: 2141, and polynucleotide variants thereof.
- 52. The transgenic plant according to claim 10, wherein said altered trait is altered seed development and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 201 and polynucleotide variants thereof.
- 53. The transgenic plant according to claim 10, wherein said altered trait is altered cell proliferation or cell differentiation and said polynucleotide sequence is SEQ ID NO: 301 and polynucleotide variants thereof.
- 54. The transgenic plant according to claim 10, wherein said altered trait is rapid development and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 435 and polynucleotide variants thereof.
- 55. The transgenic plant according to claim 10, wherein said altered trait is premature senescence and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 131, SEQ ID NO: 281, SEQ ID NO: 373, and polynucleotide variants thereof.
- 56. The transgenic plant according to claim 10, wherein said altered trait is lethality when overexpressed and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 173, SEQ ID NO: 297, and polynucleotide variants thereof.
- 57. The transgenic plant according to claim 10, wherein said altered trait is increased necrosis and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 7, 195, and polynucleotide variants thereof.
- 58. The transgenic plant according to claim 10, wherein said altered trait is an increase in seedling or plant size and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 223, SEQ ID NO: 277, SEQ ID NO: 429, and polynucleotide variants thereof.
- 59. The transgenic plant according to claim 58, wherein said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 223 and polynucleotide variants thereof, and said increase in plant size is an increase in biomass of at least 60%.
- 60. The transgenic plant according to claim 10, wherein said altered trait is decreased plant size and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 7, 57, 59, 61, 65, 303, 335, 383, 1991, 2075, 2089, and polynucleotide variants thereof.
- 61. The transgenic plant according to claim 10, wherein said altered trait is a change in leaf morphology.
- 62. The transgenic plant according to claim 61, wherein said change in leaf morphology is dark green leaves and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 141, 185, 217, 279, 295, 331, 355, 413, 447, and polynucleotide variants thereof.
- 63. The transgenic plant according to claim 61, wherein said change in leaf morphology is altered leaf shape and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 33, 59, 141, 153, 217, 237, 279, 291, 303, 355, 413, 415, and polynucleotide variants thereof.
- 64. The transgenic plant according to claim 61, wherein said change in leaf morphology is increased leaf size and mass, and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 27, 277, 435, and polynucleotide variants thereof.
- 65. The transgenic plant according to claim 61, wherein said change in leaf morphology is light green leaves and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 291, SEQ ID NO: 415, and polynucleotide variants thereof.
- 66. The transgenic plant according to claim 61, wherein said change in leaf morphology is variegated leaves and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 129 and polynucleotide variants thereof.
- 67. The transgenic plant according to claim 61, wherein said change in leaf morphology is glossy leaves and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 331, 449, 1953, and polynucleotide variants thereof.
- 68. The transgenic plant according to claim 10, wherein said altered trait is a change in seed morphology.
- 69. The transgenic plant according to claim 68, wherein said change in seed morphology is increased seed size and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 79, 115, 249, 393, 395, 399, and polynucleotide variants thereof.
- 70. The transgenic plant according to claim 68, wherein said change in seed morphology is decreased seed size and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 207 and polynucleotide variants thereof.
- 71. The transgenic plant according to claim 68, wherein said change in seed morphology is altered seed shape and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 207, 215, 249, and polynucleotide variants thereof.
- 72. The transgenic plant according to claim 10, wherein said altered trait is a change in leaf biochemistry.
- 73. The transgenic plant according to claim 72, wherein said change in leaf biochemistry is increased leaf wax and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 199, SEQ ID NO: 331, SEQ ID NO: 449, and polynucleotide variants thereof.
- 74. The transgenic plant according to claim 72, wherein said change in leaf biochemistry is an alteration in leaf prenyl lipid content and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 35, 135, 155, 203, 303, 439, and polynucleotide variants thereof.
- 75. The transgenic plant according to claim 72, wherein said change in leaf biochemistry is increased leaf xylose and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 33 and polynucleotide variants thereof.
- 76. The transgenic plant according to claim 72, wherein said change in leaf biochemistry is increased leaf anthocyanins and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 137, SEQ ID NO: 287, and polynucleotide variants thereof.
- 77. The transgenic plant according to claim 71, wherein said change in leaf biochemistry is an alteration of leaf fatty acid content and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 35, SEQ ID NO: 203, and polynucleotide variants thereof.
- 78. The transgenic plant according to claim 10, wherein said altered trait is a change in seed biochemistry.
- 79. The transgenic plant according to claim 78, wherein said change in seed biochemistry is an increase in seed oil content and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 17, 49, 75, 99, 101, 107, 119, 125, 149, 163, 283, 285, 299, 309, 313, 323, 329, 333, 345, 361, 375, 379, 383, 403, 409, 457, 2043, and polynucleotide variants thereof.
- 80. The transgenic plant according to claim 78, wherein said change in seed biochemistry is an decrease in seed oil content and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 21, 29, 39, 97, 193, 235, 241, 245, 247, 259, 303, 327, 427, 439, and polynucleotide variants thereof.
- 81. The transgenic plant according to claim 78, wherein said change in seed biochemistry is an alteration in seed fatty acid content and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 171, 283, 421, and polynucleotide variants thereof.
- 82. The transgenic plant according to claim 78, wherein said change in seed biochemistry is an increase in seed protein content and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 17, 37, 39, 99, 205, 259, 273, 315, 339, 341, 401, 439, and polynucleotide variants thereof.
- 83. The transgenic plant according to claim 78, wherein said change in seed biochemistry is a decrease in seed protein content and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 75, 329, 363, 375, 383, and polynucleotide variants thereof.
- 84. The transgenic plant according to claim 78, wherein said change in seed biochemistry is an alteration in seed prenyl lipid content and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 35, 135, 155, 439, 443, and polynucleotide variants thereof.
- 85. The transgenic plant according to claim 78, wherein said change in seed biochemistry is an alteration in seed glucosinolate profile and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 91, SEQ ID NO: 425, and polynucleotide variants thereof.
- 86. The transgenic plant according to claim 78, wherein said change in seed biochemistry is an increase in seed anthocyanins and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 137 and polynucleotide variants thereof.
- 87. The transgenic plant according to claim 10, wherein said altered trait is an increase in root anthocyanins and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 137 and polynucleotide variants thereof.
- 88. The transgenic plant according to claim 10, wherein said altered trait is an increase in plant anthocyanins and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 65, SEQ ID NO: 137, SEQ ID NO: 287, and polynucleotide variants thereof.
- 89. The transgenic plant according to claim 10, wherein said altered trait is an alteration in light response or shade avoidance, and said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 23, 61, 257, 263, 289, 291, 335, 415, 445, and polynucleotide variants thereof.
- 90. A method of using a transgenic plant according to claim 1 to grow a progeny plant, the method comprising:
(a) crossing the transgenic plant with itself or another plant; (b) selecting seed that develops as a result of said crossing; and (c) growing the progeny plant from the seed.
- 91. The method according to claim 90, wherein:
said progeny plant expresses mRNA that encodes a DNA-binding protein that binds to a DNA regulatory sequence and induces expression of a plant trait gene; said mRNA is expressed at a level greater than a non-transformed plant; and said progeny plant is characterized by a change in a plant trait compared to said non-transformed plant; wherein said non-transformed plant does not comprise the recombinant polynucleotide.
- 92. An expression cassette comprising:
(1) a constitutive, inducible, or tissue-specific promoter; and (2) a recombinant polynucleotide having a polynucleotide sequence, or a complementary polynucleotide sequence thereof, selected from the group consisting of:
(a) a polynucleotide sequence encoding a polypeptide, wherein said polypeptide is selected from the group consisting of SEQ ID NO: 2N, wherein N=1-229, SEQ ID NO: 467; 488-490; 501-503; 505; 512-515; 521-522; 525-526; 528; 530; 534-537; 540; 558-559; 569; 587-594; 597; 607-609; 621-626; 635-639; 665-669; 708-713; 720-721; 736-739; 742; 780-807; 824; 835-837; 851-854; 865-867; 890-891; 903-907; 910-913; 922-923; 926; 933-934; 943; 953-960; 966-967;987-988;994; 1011; 1035-1042; 1064-1073; 1081-1090; 1105-1110; 1122; 1129-1133; 1139-1141; 1157-1158; 1176-1186; 1191; 1200-1201; 1221-1248; 1254-1257; 1263; 1270; 1288-1291; 1302; 1310-1314; 1324-1327; 1338-1339; 1342-1343; 1362-1364; 1378; 1391-1392; 1395; 1399-1418; 1433; 1453-1454; 1457-1459; 1466-1467; 1492-1498; 1500-1501; 1503-1504; 1522; 1528; 1533-1535; 1540-1541; 1563-1566; 1572; 1583-1586; 1593-1594; 1621-1624; 1645-1646; 1655-1658; 1670; 1674; 1681; 1687; 1701-1705; 1710-1713; 1727; 1735-1737; 1743; 1754-1756; 1761-1762; 1765; 1769; 1781; 1785; 1790; 1805; 1813; 1838-1846; 1857; 1863; 1874-1875; 1883-1884; 1897-1901; 1911-1912; 1917-1920; 1929-1930; 1937-1939; 1942-1943; and SEQ ID NO: 2N, wherein N=974-1101; (b) a polynucleotide sequence encoding a polypeptide, wherein said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 2N-1, wherein N=1-229, SEQ ID NO: 459-466; 468-487; 491-500; 504; 506-511; 516-520; 523-524; 527; 529; 531-533; 538-539; 541-557; 560-568; 570-586; 595-596; 598-606; 610-620; 627-634; 640-664; 670-707; 714-719; 722-735; 740-741; 743-779; 808-823; 825-834; 838-850; 855-864; 868-889; 892-902; 908-909; 914-921; 924-925; 927-932; 935-942; 944-952; 961-965; 968-986; 989-993; 995-1010; 1012-1034; 1043-1063; 1074-1080; 1091-1104; 1111-1121; 1123-1128; 1134-1138; 1142-1156; 1159-1175; 1187-1190; 1192-1199; 1202-1220; 1249-1253; 1258-1262; 1264-1269; 1271-1287; 1292-1301; 1303-1309; 1315-1323; 1328-1337; 1340-1341; 1344-1361; 1365-1377; 1379-1390; 1393-1394; 1396-1398; 1419-1432; 1434-1452; 1455-1456; 1460-1465; 1468-1491; 1499; 1502; 1505-1521; 1523-1527; 1529-1532; 1536-1539; 1542-1562; 1567-1571; 1573-1582; 1587-1592; 1595-1620; 1625-1644; 1647-1654; 1659-1669; 1671-1673; 1675-1680; 1682-1686; 1688-1700; 1706-1709; 1714-1726; 1728-1734; 1738-1742; 1744-1753; 1757-1760; 1763-1764; 1766-1768; 1770-1780; 1782-1784; 1786-1789; 1791-1804; 1806-1812; 1814-1837; 1847-1856; 1858-1862; 1864-1873; 1876-1882; 1885-1896; 1902-1910; 1913-1916; 1921-1928; 1931-1936; 1940-1941; 1944-1946, and SEQ ID NO: 2N-1, wherein N=974-1101; (c) a polynucleotide sequence encoding the polypeptide sequence of (a) with conservative substitutions as defined in Table 2, wherein said polypeptide sequence of (a) with conservative substitutions is a transcription factor; (d) a variant of the polynucleotide sequences of (a) or (b), which is at least 80% identical to a sequence of (a) or (b), and wherein said sequence variant encodes a polypeptide that is a transcription factor; (e) an orthologous sequence of the polynucleotide sequences of (a) or (b), which is at least 80% identical to a sequence of (a) or (b), and wherein said orthologous sequence encodes a polypeptide that is a transcription factor; (f) a paralogous sequence of the polynucleotide sequences of (a) or (b), which is at least 80% identical to a sequence of (a) or (b), and wherein said paralogous sequence encodes a polypeptide that is a transcription factor; (g) a polynucleotide sequence encoding a polypeptide comprising a conserved domain that exhibits at least 80% sequence homology with the conserved domain of the polypeptide of (a), wherein said polypeptide comprising a conserved domain of a transcription factor; and wherein said conserved domain of (a) is bounded by amino acid residue coordinates according to Table 5; and (h) a polynucleotide that hybridizes to the polynucleotide of (a) or (b) under stringent conditions; wherein said recombinant polynucleotide is operably linked to said promoter.
- 93. A host cell comprising the expression cassette according to claim 92.
- 94. A method for producing a modified plant having a modified trait, the method comprising:
(a) selecting a polynucleotide that encodes a polypeptide, wherein said polynucleotide has a sequence, or a complementary sequence thereof, selected from the group consisting of:
(i) a polynucleotide sequence encoding a polypeptide, wherein said polypeptide is selected from the group consisting of SEQ ID NO: 2N, wherein N=1-229, SEQ ID NO: 467; 488-490; 501-503; 505; 512-515; 521-522; 525-526; 528; 530; 534-537; 540; 558-559; 569; 587-594; 597; 607-609; 621-626; 635-639; 665-669; 708-713; 720-721; 736-739; 742; 780-807; 824; 835-837; 851-854; 865-867; 890-891; 903-907; 910-913; 922-923; 926; 933-934; 943; 953-960; 966-967; 987-988; 994; 1011; 1035-1042; 1064-1073; 1081-1090; 1105-1110; 1122; 1129-1133; 1139-1141; 1157-1158; 1176-1186; 1191; 1200-1201; 1221-1248; 1254-1257; 1263; 1270; 1288-1291; 1302; 1310-1314; 1324-1327; 1338-1339; 1342-1343; 1362-1364; 1378; 1391-1392; 1395; 1399-1418; 1433; 1453-1454; 1457-1459; 1466-1467; 1492-1498; 1500-1501; 1503-1504; 1522; 1528; 1533-1535; 1540-1541; 1563-1566; 1572; 1583-1586; 1593-1594; 1621-1624; 1645-1646; 1655-1658; 1670; 1674; 1681; 1687; 1701-1705; 1710-1713; 1727; 1735-1737; 1743; 1754-1756; 1761-1762; 1765; 1769; 1781; 1785; 1790; 1805; 1813; 1838-1846; 1857; 1863; 1874-1875; 1883-1884; 1897-1901; 1911-1912; 1917-1920; 1929-1930; 1937-1939; 1942-1943; and SEQ ID NO: 2N, wherein N=974-1101; (ii) a polynucleotide sequence encoding a polypeptide, wherein said polynucleotide sequence is selected from the group consisting of SEQ ID NO: 2N-1, wherein N=1-229, SEQ ID NO: 459-466; 468-487; 491-500; 504; 506-511; 516-520; 523-524; 527; 529; 531-533; 538-539; 541-557; 560-568; 570-586; 595-596; 598-606; 610-620; 627-634; 640-664; 670-707; 714-719; 722-735; 740-741; 743-779; 808-823; 825-834; 838-850; 855-864; 868-889; 892-902; 908-909; 914-921; 924-925; 927-932; 935-942; 944-952; 961-965; 968-986; 989-993; 995-1010; 1012-1034; 1043-1063; 1074-1080; 1091-1104; 1111-1121; 1123-1128; 1134-1138; 1142-1156; 1159-1175; 1187-1190; 1192-1199; 1202-1220; 1249-1253; 1258-1262; 1264-1269; 1271-1287; 1292-1301; 1303-1309; 1315-1323; 1328-1337; 1340-1341; 1344-1361; 1365-1377; 1379-1390; 1393-1394; 1396-1398; 1419-1432; 1434-1452; 1455-1456; 1460-1465; 1468-1491; 1499; 1502; 1505-1521; 1523-1527; 1529-1532; 1536-1539; 1542-1562; 1567-1571; 1573-1582; 1587-1592; 1595-1620; 1625-1644; 1647-1654; 1659-1669; 1671-1673; 1675-1680; 1682-1686; 1688-1700; 1706-1709; 1714-1726; 1728-1734; 1738-1742; 1744-1753; 1757-1760; 1763-1764; 1766-1768; 1770-1780; 1782-1784; 1786-1789; 1791-1804; 1806-1812; 1814-1837; 1847-1856; 1858-1862; 1864-1873; 1876-1882; 1885-1896; 1902-1910; 1913-1916; 1921-1928; 1931-1936; 1940-1941; 1944-1946, and SEQ ID NO: 2N-1, wherein N=974-1101; (iii) a polynucleotide sequence encoding the polypeptide sequence of (i) with conservative substitutions as defined in Table 2, wherein said polypeptide sequence of (i) with conservative substitutions is a transcription factor; (iv) a variant of the polynucleotide sequences of (a) or (b), which is at least 80% identical to a sequence of (i) or (ii), and wherein said sequence variant encodes a polypeptide that is a transcription factor; (v) an orthologous sequence of the polynucleotide sequences of (i) or (ii), which is at least 80% identical to a sequence of (i) or (ii), and wherein said orthologous sequence encodes a polypeptide that is a transcription factor; (vi) a paralogous sequence of the polynucleotide sequences of (i) or (ii), which is at least 80% identical to a sequence of (i) or (ii), and wherein said paralogous sequence encodes a polypeptide that is a transcription factor; (vii) a polynucleotide sequence encoding a polypeptide comprising a conserved domain that exhibits at least 80% sequence homology with the conserved domain of the polypeptide of (i), wherein said polypeptide comprising a conserved domain of a transcription factor; and wherein said conserved domain of (i) is bounded by amino acid residue coordinates according to Table 5, and (viii) a polynucleotide that hybridizes to the polynucleotide of (i) or (ii) under stringent conditions; (b) inserting the polynucleotide into an expression cassette according to claim 92;(c) introducing the expression cassette into a plant or a cell of a plant to overexpress the polypeptide, thereby producing said modified plant; and (d) selecting said modified plant having said modified trait.
- 95. The method according to claim 94, wherein:
the transgenic plant possesses an altered trait as compared to a non-transformed plant; or the transgenic plant exhibits an altered phenotype as compared to said non-transformed plant; or the transgenic plant expresses an altered level of one or more genes associated with a plant trait as compared to said non-transformed plant; wherein said non-transformed plant does not comprise the recombinant polynucleotide.
- 96. The method according to claim 95, wherein said hybridization occurs in the presence of 250 mM NaCl, 25 mM trisodium citrate, 1% SDS, and 50% formamide at 42° C. and is maintained when washed twice for a total of 60 minutes under stringent wash conditions of about 2×SSC and 0.1% SDS at 65° C.
- 97. The method according to claim 95, wherein the plant is selected from the group consisting of: soybean, wheat, corn, potato, cotton, rice, oilseed rape, sunflower, alfalfa, clover, sugarcane, turf, banana, blackberry, blueberry, strawberry, raspberry, cantaloupe, carrot, cauliflower, coffee, cucumber, eggplant, grapes, honeydew, lettuce, mango, melon, onion, papaya, peas, peppers, pineapple, pumpkin, spinach, squash, sweet corn, tobacco, tomato, watermelon, mint and other labiates, rosaceous fruits, and vegetable brassicas.
- 98. The method according to claim 95, wherein the encoded polypeptide is expressed and regulates transcription of a gene.
- 99. The method according to claim 95, further comprising a constitutive, inducible, or tissue-specific promoter operably linked to said polynucleotide sequence or said complementary polynucleotide sequence.
- 100. The method according to claim 95, wherein said altered trait is a trait selected from the group consisting of enhanced tolerance to abiotic stress, enhanced tolerance to glyphosate, altered hormone sensitivity, altered disease resistance, altered sugar sensing, earlier flowering, later flowering, altered flower structure, altered inflorescence architecture, altered shoot meristem development, altered branching pattern, reduced apical dominance, altered trichome density, altered stem morphology, increased root growth, increased root hairs, altered seed development, altered seed germination, altered cell differentiation, altered cell proliferation, rapid plant development, premature senescence, lethality when overexpressed, increased necrosis, increased plant size, larger seedlings, more compact plants, dark green leaves, leaf shape, light green leaves, variegation, glossy leaves, seed coloration, increased seed size, decreased seed size, altered seed shape, increased leaf wax, altered leaf prenyl lipid content, increased leaf insoluble sugars, increased leaf anthocyanins, altered leaf fatty acid content, increased seed oil, decreased seed oil, altered seed fatty acid content, increased seed protein, decreased seed protein, altered seed prenyl lipid content, increased seed anthocyanins, increased root anthocyanins, altered light response, altered shade avoidance, or increased plant anthocyanin level.
- 101. A method of identifying a factor that is modulated by or interacts with a polypeptide encoded by the polynucleotide sequence of claim 1, said method comprising:
expressing a polypeptide encoded by said polynucleotide sequence of claim 1 in a plant; and identifying at least one factor that is modulated by or interacts with said polypeptide.
- 102. A method for identifying at least one downstream polynucleotide sequence that is subject to a regulatory effect of any of the polypeptides of claim 1, said method comprising:
expressing any of the polypeptides of claim 1 in a plant cell; and identifying RNA or protein produced as a result of said expression.
- 103. The method of claim 102, wherein said identifying is by Northern analysis, RT-PCR, microarray gene expression assays, reporter gene expression systems subtractive hybridization, differential display, representational differential analysis, or by two-dimensional gel electrophoresis of one or more protein products.
- 104. The transgenic plant of claim 1; wherein the conserved domain comprises consecutive amino acid residues Ser-Ser-Lys/Arg-Tyr/Phe-Gly-Val-Val-Pro-Gln-Pro-Asn-Gly-Arg-Typ-Gly-Ala-Gln-Ile-Tyr-Glu-Lys/Arg-His-Gln-Arg-Val-Trp-Leu-Gly-Thr-Phe-Xaa-Glu/Asp-Glu-Glu/Asp-Glu/Asp-Ala-Ala/Val-Arg-Ala/Ser-Tyr-Asp-Val/Ile-Ala/Val-Val/Ala-Xaa-Arg-Phe/Tyr-Arg-Arg/Gly-Arg-Asp-Ala-Val-Thr/Val-Asn-Phe-Lys/Arg of SEQ ID NO: 170, wherein Xaa is any amino acid residue.
- 105. The transgenic plant of claim 1, wherein the polynucleotide sequence is selected from the group consisting of SEQ ID NO: 169, 369, 1159 through 1175, 1949, and 2071.
- 106. The transgenic plant of claim 1, wherein the polypeptide is selected from the group consisting of SEQ ID NO: 170, 370, 1176 through 1186, 1950, and 2072.
- 107. The expression cassette of claim 92; wherein the conserved domain comprises consecutive amino acid residues Ser-Ser-Lys/Arg-Tyr/Phe-Gly-Val-Val-Pro-Gln-Pro-Asn-Gly-Arg-Typ-Gly-Ala-Gln-Ile-Tyr-Glu-Lys/Arg-His-Gln-Arg-Val-Trp-Leu-Gly-Thr-Phe-Xaa-Glu/Asp-Glu-Glu/Asp-Glu/Asp-Ala-Ala/al-Arg-Ala/Ser-Tyr-Asp-Val/Ile-Ala/al-Val/Ala-Xaa-Arg-Phe/Tyr-Arg-Arg/Gly-Arg-Asp-Ala-Val-Thr/Val-Asn-Phe-Lys/Arg of SEQ ID NO: 170, wherein Xaa is any amino acid residue.
- 108. The expression cassette of claim 92, wherein the polynucleotide sequence is selected from the group consisting of SEQ ID NO: 169, 369, 1159 through 1175, 1949, and 2071.
- 109. The expression cassette of claim 92, wherein the polypeptide is selected from the group consisting of SEQ ID NO: 170, 370, 1176 through 1186, 1950, and 2072.
- 110. The method of claim 94; wherein the conserved domain comprises consecutive amino acid residues Ser-Ser-Lys/Arg-Tyr/Phe-Gly-Val-Val-Pro-Gln-Pro-Asn-Gly-Arg-Typ-Gly-Ala-Gln-le-Tyr-Glu-Lys/Arg-His-Gln-Arg-Val-Trp-Leu-Gly-Thr-Phe-Xaa-Glu/Asp-Glu-Glu/Asp-Glu/Asp-Ala-Ala/Val-Arg-Ala/Ser-Tyr-Asp-Val/Ile-Ala/Val-Val/Ala-Xaa-Arg-Phe/Tyr-Arg-Arg/Gly-Arg-Asp-Ala-Val-Thr/Val-Asn-Phe-Lys/Arg of SEQ ID NO: 170, wherein Xaa is any amino acid residue.
- 111. The method of claim 94, wherein the polynucleotide sequence is selected from the group consisting of SEQ ID NO: 169, 369, 1159 through 1175, 1949, and 2071.
- 112. The method of claim 94, wherein the polypeptide is selected from the group consisting of SEQ ID NO: 170, 370, 1176 through 1186, 1950, and 2072.
RELATIONSHIP TO COPENDING APPLICATIONS
[0001] This application claims the benefit of U.S. Non-provisional application Ser. No. 09/837,944; filed Apr. 18, 2001; U.S. Provisional Application No. 60/310,847, filed Aug. 9, 2001; U.S. Non-provisional application Ser. No. 09/934,455, filed Aug. 22, 2001; U.S. Provisional Application No. 60/336,049, filed Nov. 19, 2001; U.S. Provisional Application No. 60/338,692, filed Dec. 11, 2001; U.S. Non-provisional application Ser. No. 10/171,468, filed Jun. 14, 2002; U.S. Non-provisional application Ser. No. 10/225,066, filed Aug. 9, 2002; U.S. Non-provisional application Ser. No. 10/225,067, filed Aug. 9, 2002; and U.S. Non-provisional application Ser. No. 10/225,068, filed Aug. 9, 2002, the contents of which are hereby incorporated by reference in their entirety.
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09837944 |
Apr 2001 |
US |
Child |
10374780 |
Feb 2003 |
US |